Serum prolactin response to metoclopramide during status epilepticus

J Neurol Neurosurg Psychiatry. 1992 Aug;55(8):685-7. doi: 10.1136/jnnp.55.8.685.

Abstract

Transient elevation of serum prolactin frequently follows generalised tonic-clonic and complex partial seizures. However, the levels of prolactin during status epilepticus are not increased above the normal range. Exhaustion of central prolactin supplies has been proposed as a possible mechanism for the absence of prolactin increase during status epilepticus. To test this hypothesis we injected intravenous metoclopramide (10 mg) in eight consecutive patients with status epilepticus. One patient had generalised tonic-clonic status epilepticus. Seven patients had EEG-verified non-convulsive status epilepticus, consisting of one typical absence status, one atypical absence status and five complex partial status epilepticus. Metoclopramide raised the mean (SD) prolactin levels at least five-fold in all patients, from 5.8 (8.0) micrograms/l to 87.0 (39.0) micrograms/l, within 60 minutes after the injection. Thus the mechanism for low prolactin values in status epilepticus is not cellular depletion of stored prolactin, but more likely an altered regulation, presumably induced by prolonged seizure activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anticonvulsants / therapeutic use
  • Dopamine Antagonists
  • Electroencephalography / drug effects
  • Epilepsy, Absence / drug therapy
  • Epilepsy, Absence / physiopathology
  • Epilepsy, Complex Partial / drug therapy
  • Epilepsy, Complex Partial / physiopathology
  • Female
  • Humans
  • Male
  • Metoclopramide*
  • Middle Aged
  • Prolactin / blood*
  • Receptors, Dopamine / physiology*
  • Status Epilepticus / drug therapy
  • Status Epilepticus / physiopathology*

Substances

  • Anticonvulsants
  • Dopamine Antagonists
  • Receptors, Dopamine
  • Prolactin
  • Metoclopramide